Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Pseudoephedrine

    • Product Name Pseudoephedrine
    • Alias Sudafed
    • Einecs 215-539-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    756019

    Generic Name Pseudoephedrine
    Drug Class Decongestant
    Common Brand Names Sudafed, Nexafed
    Dosage Forms Tablet, Extended-release tablet, Liquid
    Route Of Administration Oral
    Primary Use Relief of nasal congestion
    Mechanism Of Action Alpha-adrenergic agonist, causes vasoconstriction
    Prescription Status Behind-the-counter (in many regions)
    Half Life 4-8 hours
    Common Side Effects Insomnia, nervousness, dizziness, headache
    Contraindications Severe hypertension, severe coronary artery disease
    Pregnancy Category Category C (US FDA)
    Controlled Substance Status Regulated due to potential use in methamphetamine production
    Metabolism Hepatic
    Excretion Renal

    As an accredited Pseudoephedrine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White and red blister pack labeled “Pseudoephedrine 60 mg,” containing 24 tablets, with dosage instructions and pharmacy warnings prominently displayed.
    Shipping Pseudoephedrine is shipped in compliance with strict legal regulations due to its use in controlled substances. It is securely packaged in tamper-evident containers and labeled according to hazardous materials guidelines. Shipping requires detailed documentation and may involve tracking, signature confirmation, and adherence to both national and international regulatory standards.
    Storage Pseudoephedrine should be stored in a tightly closed container at room temperature, ideally between 15°C and 30°C (59°F and 86°F), away from moisture, heat, and direct sunlight. Keep the storage area dry and well-ventilated, and ensure the chemical is out of reach of unauthorized personnel, especially children. Adhere to all legal and safety regulations regarding pseudoephedrine storage.
    Application of Pseudoephedrine

    Applications of Pseudoephedrine in Industrial Manufacturing

    Pseudoephedrine serves as a strategic specialty raw material in pharmaceutical manufacturing, with narrowly defined industrial applications. Below, we detail its authentic downstream uses, focusing on regulatory compliance, formulation practice, process incorporation, and the resulting finished goods manufactured by our global clientele.

    1. Oral Nasal Decongestant Tablet Production

    Pharmaceutical manufacturers incorporate pseudoephedrine salts into oral solid dosage forms as active pharmaceutical ingredients (APIs) for acute and chronic nasal congestion. Global regulatory frameworks strictly control sourcing, batch traceability, and identity verification, dictating specifications from initial API handling through to tableting and packaging. Its inclusion level directly affects therapeutic action and compliance with maximum daily dosage limits, demanding precise process controls at every production stage.

    Industry compliance standards

    • United States Pharmacopeia (USP) Monograph for Pseudoephedrine Hydrochloride
    • European Pharmacopoeia (Ph. Eur.) requirements for solid dosage forms
    • Current Good Manufacturing Practice (cGMP, 21 CFR Parts 210/211)
    • FDA Code of Federal Regulations for Over-the-Counter (OTC) products containing decongestants

    Typical usage ratio

    • Each tablet batch generally incorporates pseudoephedrine salts at 30–120 mg per unit (0.7–1.5% w/w in core mix), optimized according to formulation for single or extended-release profiles and in compliance with per-dose legal limits in target markets.

    Downstream process integration

    • Formulation and blending: Direct API charging to high-shear mixer with excipients
    • Granulation: Wet or dry granulation depending on release profile
    • Compression: Tableting line, with in-process content uniformity checks
    • Coating and blister packaging: For moisture stability and tamper evidence

    Final product types

    • Immediate-release nasal decongestant tablets
    • Extended-release sinus relief caplets
    • Fixed combination tablets (e.g., with antihistamines or analgesics)

    2. Combination Cold and Flu Syrup Manufacturing

    Liquid oral formulations frequently combine pseudoephedrine with other actives—such as acetaminophen, dextromethorphan, or antihistamines—for multi-symptom relief in OTC medicines. These syrups require close control of solubility, taste-masking excipients, and consistent API concentration to satisfy both pharmacopoeial standards and organoleptic properties. Accurate dosing and homogenous dispersion within the syrup matrix remain critical to avoid batch failures and regulatory holds.

    Industry compliance standards

    • British Pharmacopoeia (BP) and USP monographs for pseudoephedrine and combination liquid dosages
    • FDA OTC Drug Review and labeling guidelines for oral solutions
    • GMP for liquid pharmaceutical manufacturing (EU GMP Volume 4 Annex 1)
    • Regional Health Authority product registration (e.g., Health Canada NPN requirements)

    Typical usage ratio

    • API concentrations normally range from 15–30 mg per 5 ml dose (ca. 0.3–0.5% w/v of finished syrup), adjusted for pediatric or adult indications and in line with jurisdictional limits.

    Downstream process integration

    • Dissolution: API dissolution in aqueous phase under controlled temperature
    • Syrup compounding: Integration with sweeteners, viscosity agents, flavors, and colorants
    • Homogenization: Recirculating blend tank to ensure content uniformity
    • Hot-fill or sterile fill: Dosing into pre-sterilized bottles, with automated capping and labeling

    Final product types

    • Non-prescription cold and flu relief syrups
    • Pediatric oral decongestant mixtures
    • Multi-symptom throat relief suspensions

    3. Effervescent Antihistamine-Decongestant Tablet Processing

    Effervescent technologies enable the rapid delivery of active ingredients, addressing compliance and palatability challenges for specific patient groups. Pseudoephedrine’s physicochemical behavior within effervescent matrices requires precise formulation with acid and alkali reactants to protect stability and achieve desired dissolution profiles. Integration into high-output compression lines demands validated procedures and tailored handling protocols for humidity and temperature sensitivities.

    Industry compliance standards

    • European Pharmacopoeia effervescent tablet requirements
    • WHO GMP guidelines for oral effervescent products
    • ICH Q6A specifications for finished product uniformity
    • National regulatory thresholds for pseudoephedrine-containing OTC medicines

    Typical usage ratio

    • Typical effervescent units incorporate 30–60 mg pseudoephedrine per tablet (0.6–1.2% total tablet weight), contingent on co-formulant mass and regulatory ceiling per single dose.

    Downstream process integration

    • Dry mixing: Blending pseudoephedrine with acids, bicarbonates, binders, and flavors under climate-controlled conditions
    • Compaction: Direct compression into effervescent tablets using rotary presses designed to minimize contact with ambient humidity
    • Sealing: Immediate foil wrapping to prevent premature effervescent reaction
    • Packing: Cartoning for distribution to retail or clinical channels

    Final product types

    • Effervescent decongestant-antihistamine tablets
    • Travel-size sinus relief dissolving tabs

    4. Nasal Inhaler Cartridge Manufacturing

    Medical device companies employ pseudoephedrine for the refillable solid matrix or impregnated fiber cores of nasal inhalers, enabling targeted delivery to the nasal mucosa for congestion relief. Formulation and process parameters must ensure rapid vaporization, dose reproducibility, and stability during prolonged storage, while strictly adhering to device and pharmaceutical quality regulations for the intended target region.

    Industry compliance standards

    • ISO 13485 Medical Device Quality Management Systems
    • USP monograph for pseudoephedrine nasal administration
    • Relevant device combination product guidelines (FDA 21 CFR 820)
    • Directive 93/42/EEC for medical devices (Europe)

    Typical usage ratio

    • Pseudoephedrine load in each inhaler core typically ranges from 50–75 mg per single-use cartridge, pre-calculated based on emission rate and product shelf-life requirements.

    Downstream process integration

    • Impregnation: Loading and dispersal of pseudoephedrine solution into absorbent matrix using volumetric dosing systems
    • Drying: Controlled air or vacuum drying to ensure complete carrier absorption
    • Device assembly: Encapsulation of dried cartridge into sealed inhaler body
    • Final QC: Leak, microbiological, and dose emission tests per batch

    Final product types

    • Disposable nasal decongestant inhalers
    • Multi-dose vapor inhaler sticks for fast-acting nasal relief

    5. Pharmaceutical Intermediate Synthesis for Controlled Drug Manufacturing

    In advanced synthetic operations, pseudoephedrine acts as a chiral source or protected intermediate enabler for tertiary chemical conversion to regulated API molecules under custom synthesis contracts. These processes mandate traceable origin, batch-level containment, and documentation required for scheduled precursor materials. Custom synthesis projects rely on purity, consistent isomer ratios, and audit readiness for international narcotics and precursor regulations.

    Industry compliance standards

    • UN Convention on Psychotropic Substances precursor reporting (List I/II)
    • Controlled Substances Act (CSA, 21 U.S.C. § 801)
    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • Local precursor registration and audit schemes (e.g., German BtMG, UK Misuse of Drugs Regulations)

    Typical usage ratio

    • Custom batch sizes and input ratios vary based on synthetic target and downstream product; mole-to-mole conversion rates calculated for specific process route (e.g., 0.1–1.0 molar excess as needed for chiral synthesis steps).

    Downstream process integration

    • Input to specialized reactor as initial chiral intermediate or protected precursor
    • Chemoselective functional group manipulation (e.g., N-demethylation, reductive amination)
    • Purification: Distillation, crystallization, chiral HPLC separation as required for final API quality
    • Full batch documentation and chain-of-custody audit preparation prior to API export or further downstream conversion

    Final product types

    • Advanced pharmaceutical intermediates under controlled licenses
    • Chiral building blocks for custom API synthesis projects
    Free Quote

    Competitive Pseudoephedrine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Pseudoephedrine: Direct from a Chemical Producer’s Perspective

    What Pseudoephedrine Brings to Manufacturing and Healthcare

    We produce pseudoephedrine with a focus on reliability, safety, and consistency. Over many years in the fine chemical industry, we have seen how needs shift in both pharmaceutical production and downstream industries. The methods for making this compound require care, knowledge, and strong oversight. Real-world experience proves that every batch tells its own story. Purity, physical appearance, and stability all play a part in how our partners work with it—and what patients finally experience.

    Pseudoephedrine carries weight in the pharmaceutical world, especially as a decongestant ingredient in cold and allergy medications. But what often doesn’t get enough attention is the chemistry behind it. We understand that every microgram counts for global firms formulating trusted brands and local companies handling regional supply chains. Minor impurities can trigger callbacks, regulatory issues, and lost confidence. So, from the reactor to downstream handling, our teams monitor every step, keep records, and engage in continuous process improvement. Many talk about “quality,” but consistency only comes from tireless supervision and honest reviews of each new batch.

    Defining Product Quality: Physical and Chemical Properties

    Most customers ask about product specifications: melting point, particle size, optical rotation, and water content. Here, the purity often clocks in above 99%, and residual solvents must fall well under the limits set by pharmacopeias. Each batch meets or exceeds standards for pharmaceutical pseudoephedrine hydrochloride or sulfate, in line with published USP, EP, and JP standards. We monitor all these points, and any deviation triggers an immediate review. From color to stability upon long-term storage, our experience shows even slight fluctuations can spark trouble downstream. Moisture content has a direct effect on tablet compression and shelf life. We use loss on drying, Karl Fischer titration, and advanced spectroscopic methods to ensure actual values—not just assumptions.

    Many in the supply chain focus on assay alone, but particle size distribution matters as well. Too fine, and there’s a risk of dust and problems in blending; too coarse, and dissolution becomes sluggish. Over the years, we have refined crystallization steps to produce material that flows well and presses consistently into granules, tablets, or capsules. Visual inspection, sieve analysis, and flow testing back every shipment—we don’t just rely on paperwork, since our clients’ machinery and end-products are on the line. Color often seems minor, but pharmaceutical companies quickly reject batches with any off-white or yellowish tint, viewing them as signs of potential contamination or process deviation.

    Why Our Approach Yields Stable Performance

    Pseudoephedrine production isn’t a one-size-fits-all business. Incoming raw materials, reactor conditions, and technical staff experience all influence outcomes. Here, technicians stay on the floor, monitoring crystallization temperatures, pH, and solvent ratios. Real-time analytics matter more than ever—they catch drift before it spreads. Through many production cycles, it becomes clear that chasing maximum yield sometimes undermines process stability or product appearance. So we’ve chosen to set conservative yield and throughput targets in favor of reliable, clean product for medical applications.

    Labeling and traceability aren’t just paperwork. Starting from registered, pre-tested precursors, every lot is coded, controlled, and stored under climate conditions reviewed every quarter. Special attention goes to storage temperature, humidity, and protection from light. This isn’t academic; we’ve found that improper storage—even during short-term logistics—can cause discoloration or degrade pharmaceuticals during customer formulation trials. So we partner closely with logistics firms that understand controlled chain of custody for these sensitive compounds. Working as a manufacturer, we see where each risk hides, from contamination during packaging to temperature spikes during overseas transport.

    Practical Impacts on the Downstream Value Chain

    End users—the tablet producers, the compounders—rely on a manufacturer’s practical insight. Over the years, we’ve worked with teams facing formulation issues due to minor batch inconsistency, crystalline habit variation, or trace impurities. Loose controls make for challenging blending, off-spec dissolution curves, and film-coating headaches. By keeping physical and chemical variation minimal, we help our customers avoid extra steps, re-tests, or full batch scrapping. We take their feedback and adapt production, which in turn drives both steady output and trust.

    Time and again, real stories from our partners show that tight specifications boost process efficiency, reduce worker exposure during weighing and blending, and make for easier documentation during audits. The finer points—flowability, dust levels, ease of handling—don’t fill spec sheets, but they matter daily on the shop floor. We have witnessed how poor pseudoephedrine quality sparks months of revalidation work or lost production. So each run, from raw input to packed drum, gets tailored oversight and transparent data backing it up.

    Difference from Commodity-Grade and Competing Products

    Pseudoephedrine is commonly compared to phenylephrine for over-the-counter medications, but practical differences stand out. Large-scale tablet presses, encapsulators, and blending lines often run into fewer issues with pseudoephedrine’s physical properties. Phenylephrine is notorious for challenging stability and less predictable results in mass production, especially on high-speed commercial lines deployed by leading brands. There are also critical pharmacological distinctions—pseudoephedrine delivers a predictable decongestant effect and is valued by clinicians for its established clinical track record.

    Within our own production, we continuously compare our output not only against regulatory standards but also side-by-side with samples picked from global markets and other manufacturers. We have found that, while global suppliers may all claim compliance, subtle differences in chemical purity and particulate form matter in actual pharmaceutical applications. For example, detecting trace solvents or residual organics at low levels requires not just published methods but also deep experience watching for atypical test results. We don’t accept “nearly meets the limit”—either a shipment fits the purpose or it does not leave our warehouse. We reject more material than we ship, and this discipline turns into fewer problems for our direct customers.

    Handling Production Risks and Regulatory Scrutiny

    Manufacturing regulated substances such as pseudoephedrine means living under constant regulatory review. We welcome close inspections, because a safe product and a transparent process protect everyone—the end consumer, our clients, our own team. Regulators now track not just finished product but also precursor sourcing, operator training, and waste stream management. Our investment goes into audit readiness, both self-audits and third-party reviews, before local or foreign agencies arrive. Our production records go back for years, and real-world data from thousands of process cycles guide both routine runs and troubleshooting.

    Legislation controls on pseudoephedrine and associated products have grown tighter, and our direct experience running a production facility sets us apart from traders and intermediaries. Waste treatment, emissions capture, and local community safety factor into each day’s operations, and these aren't just tick-boxes for compliance. Every incident of improper disposal, accidental release, or lapse in documentation puts our license, reputation, and entire downstream value chain at risk. A manufacturing plant like ours has to treat regulation as both baseline and constant improvement target.

    Adapting Facilities and Skills to Stay Ahead

    The chemistry behind pseudoephedrine looks simple on paper, but facility requirements are demanding. Process intensification looks good in lab trials, yet on a real production line, managing exotherms, pressure, and solvent recovery quickly becomes a logistical and safety challenge. We run regular scenario testing with staff, update emergency protocols, and invest in training that covers not just chemistry but also logistics, safety engineering, and environmental standards. These steps guard against supply interruptions, product defects, or regulatory penalties.

    Operators with years on the job develop a practical understanding of where even small temperature excursions or material contamination can ruin part of a batch. Those skills don’t come from academic training or PowerPoint presentations. Shared experience between generations of plant staff ensures that both new and veteran practitioners catch problems early and respond fast. It’s not just about running equipment; it’s a culture of care built daily through practice.

    Ensuring Supply Chain Resilience and Global Support

    World events—natural disasters, labor disputes, export controls—periodically jolt chemical supply chains. Over multiple cycles, we’ve built alternative sourcing for primary inputs and qualified multiple transport partners to avoid disruptions. We keep strategic reserves of raw materials and finished pseudoephedrine on hand, while working with both local and global logistics firms. This proactive approach helped our customers in critical moments: extreme weather, port closures, or global health emergencies. Being a manufacturer, we handle real conditions as they arise, cutting wait times, and avoiding reliance on far-off or untested third-party logistics.

    Forecasting helps, but actual production resilience needs both on-site and off-site backup strategies. Regular, real-world drills and scenario planning have helped us refine responses—knowing that sometimes the best solution isn’t technological, but human judgment and established rapport with suppliers, regulators, and downstream users.

    Direct Support and Transparency for Industry Partners

    We believe that a manufacturer’s job doesn’t end at shipment. Questions—about formulation, shelf stability, impurity detection, and regulatory filings—reach our technical teams every week. We answer with real lab data, historic trends, and practical advice built from our own rigorous testing. Sometimes we reanalyze retained samples or provide extra documentation under urgent deadlines. We do this not as a value-add, but as a core part of responsible partnership. Our experience shows that the fastest way to resolve industry headaches is honest, thorough information and readiness to support troubleshooting or validation audits.

    We have learned that every partnership relies on mutual trust and clear communication. Our technical team visits manufacturing sites, shares process know-how, and helps develop customized handling or formulation approaches. Such support helps our partners reduce downtime, contain costs, and maintain safety and efficacy in the eyes of regulators and end-users.

    Looking Ahead: Keeping Pseudoephedrine Safe and Reliable

    Making and shipping pseudoephedrine brings both privilege and responsibility. Over time, our team has developed an appreciation for how each process improvement, staff training, or transparency measure adds up. It’s not just compliance or making the numbers; we act as both stewards of chemical technology and guardians of public trust. The daily work of refining crystallization, checking product in the lab, and collaborating with logistics partners means that our supply sees fewer detours and our customers face fewer surprises.

    Regulatory scrutiny, industrial shifts, and unforeseen disruptions will push the industry to evolve. We invest not just in equipment and analytics, but also in the skills and judgment of the real people behind each production cycle. That attitude has proven to reduce waste, mistakes, and recalls. For our partners and their end-customers, that means safer, more predictable outcomes every time they use pseudoephedrine.

    Conclusion: Experience Shapes Every Shipment

    No process in chemical manufacturing can ever be entirely risk-free, and pseudoephedrine stands among the most closely watched active pharmaceutical ingredients. Through years of experience, methodical production, and ongoing humility before regulatory and practical challenges, we’ve seen first-hand why vigilance and openness pay off. Sturdy partnerships, technical skill, and a dedication to improving each link in the chain help ensure that the pseudoephedrine reaching pharmacies and clinics matches the standards that matter most: consistent safety, reliability, and fitness for purpose. Experience in the field beats theory, and for us, the next improvement is always on the horizon.